BioNexus Gene Lab Corp (BGLC) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $8.61M | +3.5% |
| 2024 | $8.32M | -13.8% |
| 2023 | $9.66M | +44.9% |
| 2022 | $6.67M | -7.2% |
| 2021 | $7.18M | +7.8% |
| 2020 | $6.66M | +493.6% |
| 2019 | $1.12M | -26.3% |
| 2018 | $1.52M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $8.61M | +3.5% |
| 2024 | $8.32M | -13.8% |
| 2023 | $9.66M | +44.9% |
| 2022 | $6.67M | -7.2% |
| 2021 | $7.18M | +7.8% |
| 2020 | $6.66M | +493.6% |
| 2019 | $1.12M | -26.3% |
| 2018 | $1.52M | — |